A Microcosm of 2026: From Pawnshop Booms to High-Stakes Tech GamblesGlobal Report·Jul 29 at 04:18 AMNRT-4.00%ONON+4.37%
Telomir Pharmaceuticals announces annual shareholder meeting via virtual webcastPUBT·Jul 28 at 04:00 PMTELO+2.07%
Tesla Inc Stock (TSLA) Moved Down by 12.68% on Jul 23: Facts Behind the MovementTradingKey·Jul 23 at 09:19 AMTSLA+3.62%TSL+4.28%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 21 at 12:05 PMTELO+2.07%CPHI+6.31%
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Down 17.2% - Here's WhyMarket Beat·Jul 21 at 01:20 AMTELO+2.07%BAC+0.15%
Telo Genomics reports positive interim data for blood test predicting multiple myeloma relapse riskPUBT·Jul 16 at 06:02 AMTELO+2.07%
Pebble Flow electric RV towed by TELO’s MINI-sized electric truckElectrek·Jul 14 at 11:10 AMTELO+2.07%
Telo Genomics files US provisional patent for TeloView liquid biopsy MRD algorithm in multiple myelomaPUBT·Jul 9 at 06:02 AMTELO+2.07%
Telomir Reports Peer-Reviewed Preclinical Telomir-Zn Data Showing Dose-Dependent Survival & Reduced Hepatic CopperTradingView·May 20 at 07:03 AMTELO+2.07%ARKG+2.44%
Telomir Pharmaceuticals, Inc. 1Q 2026: Revenue $0 EPS $(0.03) — 10-Q SummaryTradingView·May 14 at 02:11 PMTELO+2.07%PBE+0.36%
EXCLUSIVE: Telomir Pharmaceuticals Secures FDA Nod For Its Breast Cancer Therapy To Advance Into Human Studybenzinga_article·Apr 30 at 06:46 AMTELO+2.07%PBE+0.36%